The subclone of undifferentiated components contained FGF19 and MET amplifications that is not found in the tubular component and is reported to be associated with poor prognosis in liver and gallbladder carcinomas [13, 14]. This evidence concerns the gene FGF19 and gallbladder carcinoma.